about
Preparation and solid state characterisation of chlorothiazide sodium intermolecular self-assembly suprastructure.Preparation and characterisation of novel chlorothiazide potassium solid-state salt forms: Intermolecular self assembly suprastructures.Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.Modification of the solid-state nature of sulfathiazole and sulfathiazole sodium by spray dryingDry powders for oral inhalation free of lactose carrier particles.Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material properties.Ciprofloxacin-Loaded Inorganic-Organic Composite Microparticles To Treat Bacterial Lung Infection.Materials and methods for delivery of biological drugs.Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation.Investigations into the fate of inhaled salmon calcitonin at the respiratory epithelial barrier.Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility.Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.Development and characterisation of soluble polymeric particles for pulmonary peptide delivery.Molecular structure studies of (1S,2S)-2-benzyl-2,3-dihydro-2-(1H-inden-2-yl)-1H-inden-1-ol.The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties.Sensitivity of dissolution rate to location in the paddle dissolution apparatus.The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials.Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems.Impact of alternative solid state forms and specific surface area of high-dose, hydrophilic active pharmaceutical ingredients on tabletability.Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid.Towards determining appropriate hydrodynamic conditions for in vitro in vivo correlations using computational fluid dynamics.Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties.Spray drying of budesonide, formoterol fumarate and their composites--I. Physicochemical characterisation.Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites--analysis of glass transition composition relationships.Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability.Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications.Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.Novel Iron-Whey Protein Microspheres Protect Gut Epithelial Cells from Iron-Related Oxidative Stress and Damage and Improve Iron Absorption in Fasting Adults.New aerosol formulation to control ciprofloxacin pulmonary concentration.Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating.Production of cocrystals in an excipient matrix by spray drying.Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals.Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics.Bulk, surface properties and water uptake mechanisms of salt/acid amorphous composite systems.
P50
Q33684314-AB550924-01FD-4A1A-9332-D2C63C87E806Q33758033-BF57DBCB-66C7-461F-B8BC-5EE23C6F2C42Q35912256-3B3ECD5D-D930-4941-AF3E-2310A78380D3Q35999134-B5AD9BE4-1BAB-4FE3-967F-529C17E38DCAQ38204826-90AED102-70A8-4268-8B1E-972543178B71Q38628418-D8C14DDF-BF15-402F-92D5-77A8F2FF0947Q38814073-B5A7507A-0459-43E8-A67B-4E26B1FA524BQ38987392-13AFDBA2-6D2A-458D-A003-52B52ABF3EB7Q39061441-1E4B7DBC-A506-4C93-87A8-9E3DC4B9B3D4Q39170220-B7BADF4B-D8F6-425B-ACC6-E5A0B5DBD63FQ39446362-6AB2A937-F1A1-47B6-A261-949C153B2EEAQ39494684-41A58665-A31A-432C-A51A-310919A654FEQ40332720-A9609A31-70E3-4C15-89FA-C014013FCE8DQ40692305-F02D393A-6136-4FF8-A3B1-A62D801F4828Q42246960-A93D9A93-9974-4D26-814E-BE467921D9B5Q42973890-3CCBECDD-3BCB-456D-82BF-68613E285A14Q43121413-1CCA6290-4398-4A06-981F-6341662F4C22Q43906304-4024659D-DBCF-4EA9-8DE4-4782955F88DDQ43922717-713B7A79-B8C1-497D-988E-443BD5B2AC96Q44555160-90303F5E-55B1-4E45-A40B-840070FF0E71Q44792636-2A50FC78-F68B-45D4-A088-2C28AC5B8105Q45158940-FFEFAD52-F69A-4465-80F5-E000384557FFQ45396197-C2E32DA5-D4B1-47E9-8830-56C09B79BC74Q45732960-F035B9E4-964B-4C17-B12D-331AA8C30D53Q45771129-6632A9CF-B319-48C0-A228-07067494D7ABQ45985484-98EBB4BB-AA02-4B5F-9795-D39358C3DA0CQ45999762-6C3746EF-0F4E-4B55-B614-0C4F4BC1092FQ46311146-3A56C2E3-912A-44F5-A0B7-169AA74BB79AQ46311157-D0C1B3B7-8412-47E0-BCEA-E1DDDF8CB051Q46398107-CE495B32-2BA1-421F-9671-AA8C59BA7C21Q46783198-6C1259BC-12C0-4CA6-AB36-E8311E008F7AQ46824789-818F31F2-8AA4-4316-B3DE-A016E7D348D8Q46824791-82E234EE-AEE1-45E2-9A40-91F53BEE06D8Q47232455-3EC79EAC-5F67-40E0-82C7-B9F2F96CC801Q47255385-BADF2474-83F4-48A9-901C-F70883050FF8Q47292255-FDD3638F-23FC-4A3F-8430-25E3D38250D8Q47755115-5B508998-7E80-4829-B361-24A03AF07A45Q48617603-DFF561E8-41E5-4FC4-A730-E77A9A325CD9Q50047299-285B4405-2D53-4CDA-B776-33BE488131DAQ50474793-C46C0BEB-1B4D-4624-9838-DF6599FE4386
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anne Marie Healy
@ast
Anne Marie Healy
@en
Anne Marie Healy
@es
Anne Marie Healy
@nl
type
label
Anne Marie Healy
@ast
Anne Marie Healy
@en
Anne Marie Healy
@es
Anne Marie Healy
@nl
prefLabel
Anne Marie Healy
@ast
Anne Marie Healy
@en
Anne Marie Healy
@es
Anne Marie Healy
@nl
P106
P1153
7101614452
P21
P31
P496
0000-0001-5093-9786